Therapy with adiponectin administration has shown to improve insulin resistance in animal models of obesity; however, in lipodystrophic animal cases, the complete reversal of insulin resistance requires the co-administration of leptin. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.